Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content - Volume 4 Issue 2 - November 2017

 

Serum uric acid and urinary albumin in patients of type II diabetes mellitus

 

Gulajkar Supriya Rameshrao1, Bina M Gadhiya2*, A P Thorat3

 

1Assistant Professor, 2Associate Professor, 3Professor and HOD, Department of Biochemistry, Government Medical College and Hospital, Aurangabad, Maharashtra, INDIA.

Email: gulajkarsupriya@yahoo.com

 

Abstract               Diabetes mellitus has been known to be a state of oxidative stress with excess generation of free radicals contributed by several mechanisms including hyperglycemia. Uric Acid is the final oxidation product of purine metabolism in humans. Whether Uric Acid acts as an antioxidant or prooxidant is the matter of debate. Hyperuricemia is associated with an increased risk of complications. Increased levels could be injurious to the kidneys and predictive of progression of Renal disease. Objecives of study are to estimate Uric Acid levels in type II diabetics and study its correlation with urinary albumin excretion. Fasting venous samples along with urine were collected from  patients visiting Govt Medical College, Aurangabad. Serum Uric Acid levels and urinary albumin were estimated. Uric Acid concentration was significantly higher in diabetics. Increased levels of uric acid were associated with increased urinary albumin excretion. The importance of uric acid as a risk factor for renal injury and increased urinary albumin excretion rate is worthy of further investigation.

Key Words: Serum uric acid and urinary albumin.

 

 

 

INTRODUCTION

It has been estimated that the global burden of type 2 diabetes mellitus (T2DM) for 2010 would be 285 million people (2010) which is projected to increase to 438 million in 20301. The burden of diabetes is to a large extent the consequence of macrovascular (coronary artery disease, peripheral vascular disease, and atherosclerosis) and microvascular (like retinopathy, neuropathy, and nephropathy) complications of the disease1. Diabetic nephropathy is a devastating late complication of diabetes in patients with both type 1 and 2 diabetes. Its early clinical sign is a slight elevation of urinary albumin excretion which is called microalbuminuria. If it progresses, patients will have progressive end stage renal disease (ESRD)3. There has been a growing interest in the association of hyperuricaemia with hyperglycemia since this was first described in 19234. Recently, renewed attention has been given to serum uric acid (SUA) because of its association with cardiovascular and renal disease and hypertension3. Hyperuricemia may increase the risk for renal dysfunction in patients with diabetes mellitus. Whether Uric Acid acts as an antioxidant or pro-oxidant is a matter of debate. So aim of our study is To estimate serum uric acid levels in type II DM To study correlation of uric acid with albumin excretion, Lipid profile and HbA1c in type II Diabetes Mellitus

 

MATERIALS AND METHODS

80 type II diabetics (>5yrs) visiting Govt. Medical college, Aurangabad were included in the study. Informed written consents were taken. Cross sectional study was done.

 

 


Exclusion Criteria

Alcoholics; Patients taking diuretics, uric acid lowering agents; Fever; Acute illness; UTI; Fasting venous samples were collected; Fresh midstream urine samples were collected for urinary albumin; Following parameters were assessed:

 

Table 1:

Parameters

Method

BSL

Enzymatic end point by GOD-POD

HBA1C

Ion exchange resin

Urinary albumin

Immunoturbidometric method

URIC ACID

Uricase and peroxidase method(enzymatic end point)

Cholesterol

Enzymatic end point

Triglycerides

Enzymatic end point

HDL direct

Enzymatic end point

LDL

Friedwald’s formula

On the basis of albumin excretion patients were classified as

1

Figure 1:

RESULTS

Demographic and biochemical characteristics of all the participants were analyzed as mean ± Standard Deviation (S.D.). ANOVA was applied to analyze the differences of studied characters in study groups. p value was obtained from ANOVA test as > 0.05 not significant, < 0.05 Significant and < 0.01 highly significant. Correlation coefficients (r) were calculated among various parameters in diabetic patients. Positive and negative r values were interpreted as follows: r = 0 (no correlation), r = 0 to 0.3 (poor correlation), r = 0.3 to 0.7 (considerable correlation) and r = 0.8 or more (strong correlation).

Table 1: Demographic parameters (Mean ±S.D)

Demographic parameters

Group 1

Normoalbuminuria 20

Group 2

Microalbuminuria 35

Group 3

Macroalbuminuria 25

p value

Age (years)

43.44±6.4

48.78±6.65

57.46±6.41

<0.05

Duration (years)

5.2±1.01

7.4±2.1

8.3±1.04

NS

Systolic BP

130±12.6

137±16.7

141±17.8

NS

Diastolic BP

76±9.8

84±7.6

86±8.7

NS

 

Table 2: Comparison of biochemical parameters in study groups (MEAN±SD)

Biochemical

parameters

Group1

Normoalbuminuria 20

Group2

Microalbuminuria 35

Group3

Macroalbuminuria 25

p value

Uric acid

4.32±1.12

4.84±1.16

6.18±1.0

<0.01

Urinary albumin

27.45±2.37

123.97±55.47

343.9±32.63

<0.01

BSL

147.1±24.93

185.2±21.61

208.4±31.06

<0.01

HbA1c

6.83±0.67

8.17±0.83

8.81±0.88

<0.01

Cholesterol

180.9±13.34

192.28±12.89

209.2±28.67

<0.01

Triglycerides

164.05±28.69

178.71±22.60

192.44±28.06

<0.05

HDL

44.25±5.55

37.26±6.14

33.8±6.12

<0.01

LDL

103.84±16.72

119.29±15.31

136.95±28.04

<0.01

CRET

O.8±0.2

0.84±0.3

1.04±0.4

NS

 

Uric acid levels are significantly higher in patients of Group 2 and Group 3 as compared to Group1. HbA1c,fasting BSL, lipid profile are significantly increased in patients of Group 2 and Group3 as compared to Group 1.

 

Table 3: Correlation of uric acid with other parameters

Parameters

r value

p value

Urinary Albumin

0.68

<0.01

HBA1C

0.34

<0.05

BSL

0.33

<0.01

HDL

-0.24

0.03

Cholesterol

0.31

<0.05

Triglycerides

0.21

NS

LDL

0.32

<0.05

Uric acid levels were correlated positively with urinary albumin, fasting BSL, HBA1C, cholesterol, LDL. Negative correlation was found between uric acid and HDL. There was no correlation found between Uric acid and Triglyceride levels.

2

3

Legend

Figure 1: Comparison of uric acid levels in study groups; Figure 2: Correlation of uric acid with urinary albumin; Figure 3: Correlation of uric acid with HbA1C; Figure 4: Correlation of uric acid with BSL; Figure 5: Correlation of uric acid with HDL; Figure 6: Correlation of uric acid with Cholesterol; Figure 7: Correlation of uric acid with LDL; Figure 8: Uric acid levels

 

DISCUSSION

Study evaluated the relationship between serum uric acid and albumin excretion in type II diabetes mellitus. Albuminuria is an important marker of diabetic nephropathy in type II diabetics independent of hypertension. Hyperglycemia induced oxidative stress can alter endothelial permeability leading to albuminuria. Insulin resistance in type II diabetes is related to endothelial dysfunction increasing vascular endothelial cell permeability. Serum uric acid levels were significantly higher in Group 2 and Group3 as compared to Group1.Hyperinsulinemia which is the basis of type II diabetes may decrease uric acid clearance by kidneys and increase its production. In humans uric acid is the final breakdown product of Adenosine playing an important role in the insulin resistance. Adenosine can also cause increased renal uric acid retention. Uric acid levels were positively correlated with albumin excretion and correlation was significant. Reaction of xanthine oxidase in conversion of xanthine to uric acid generates superoxide anions. Endothelial dysfunction, one of the consequences of type II diabetes mellitus is thought to be mediated in part by such reactive oxygen species. Hyperuricemia induced endothelial dysfunction and renal hypertrophy decrease renal perfusion by stimulating afferent arteriolar vascular smooth muscle cell proliferation and alters vascular permeability causing albumin excretion. Hyperuricemia can induce renin expression from juxtaglomerular cells and inhibit NOS expression in macula densa. It also Stimulates cytokines from leukocytes and chemokines from vascular smooth muscle cells. Association of albumin excretion with uric acid confirmed the effect of hyperuricemia on diabetic nephropathy. Uric acid levels were also positively correlated with HbA1c and total cholesterol and LDL and correlated negatively with HDL. Lipid profile, HbA1C, were significantly increased in group 2 and group 3 as compared to group 1. Hyperglycemia and dyslipidemia cause disorders of the albumin excretion rate by damaging the podocyte and slit diaphragm protein scaffold with overproduction of and extracellular release of oxygen radical species at the glomerular level.

 

CONCLUSION

Hyperuricemia is associated with diabetic patients and positively correlated with albumin excretion. Hyperuricemia is an independent risk factor for kidney dysfunction in patients with diabetes mellitus. Since it is relatively easy to lower uric acid levels with medications, this study suggested that not only the importance of uric acid as a risk factor for cardiovascular disease should be reconsidered, its pathogenic role of uric acid in other clinical manifestations such as renal injury and increased urinary albumin excretion rate is worthy of further investigation

 

REFERENCES

  1. Hyperuricemia and Albuminuria in Patients With Type 2 Diabetes Mellitus, IJKD 2011;5,21-24 Shokoofeh Bonakdaran,1 Maryam Hami,2 Mohammad Taghi Shakeri3
  2. High-normal serum uric acid is associated with albuminuria and impaired glomerular filtration rate in Chinese type 2 diabetic patients Chinese Medical Journal 2011;124(22):3629-3634 CAI Xiao-ling, HAN Xue-yao and JI Li-nong
  3. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005; 68: 796-801. Tseng CH.
  4. A Role for Uric Acid in the Progression of Renal Disease J Am Soc Nephrol 13: 2888–2897, 2002 Duk-hee Kang, Takahiko Nakagawa, Lili Feng,susumu Watanabe, Lin Han, Marilda Mazzali
  5. Hyperuricemia Induces Endothelial Dysfunction Kidney International, Vol. 67 (2005), pp. 1739–1742 Uday M. Khosla, Sergey Zharikov, Jennifer L. Finch, Takahiko Nakagawa, Carlos Roncal, Wei Mu, Karina Krotova, Edward R. BLOCK, SHARMA PRABHAKAR, And RICHARD J. Johnson